Form 8 (OPD) - Augmentum Fintech plc

/**/

RNS Number : 8925V Augmentum Fintech PLC 09 March 2026  

FORM 8 (OPD)   PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code")   1.         KEY INFORMATION  

(a) Full name of discloser:

Augmentum Fintech plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):      The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:      Use a separate form for each offeror/offeree

Augmentum Fintech plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:      The latest practicable date prior to the disclosure

9 March 2026

(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?      If it is a cash offer or possible cash offer, state "N/A"

N/A  

  2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE   If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.   (a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates  

Class of relevant security:  

Ordinary Shares of £0.01 each

   

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

nil

0

nil

0

(2) Cash-settled derivatives:  

nil

0

nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

nil

0

nil

0

       TOTAL:

nil

0

nil

0

  All interests and all short positions should be disclosed.   Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).   Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).   (b)        Rights to subscribe for new securities  

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

    3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE  

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

  Directors' interests (a)  Ordinary shares held by the directors of Augmentum Fintech plc  

Name

Number of Ordinary Shares

Percentage of Issued Share Capital

William Reeve

124,000

0.07%

Karen Brade

39,019

0.02%

David Haysey and spouse

94,230

0.06%

Sir William Russell and spouse

270,000

0.16%

    (b)  Ordinary shares held by the directors of Augmentum Fintech Management Limited(1)  

Name

Number of Ordinary Shares

Percentage of Issued Share Capital



Tim Levene and spouse

2,774,203

1.66%

Richard Matthews

508,000

0.30%

    Augmentum Fintech plc does not have share options or a share scheme.     (1)       A wholly owned subsidiary of Augmentum Fintech plc responsible for managing its portfolio of investment assets

  Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).   Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).   4.         OTHER INFORMATION   (a)        Indemnity and other dealing arrangements  

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

  None  

  (b)        Agreements, arrangements or understandings relating to options or derivatives  

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"

  None    

  (c)        Attachments   Are any Supplemental Forms attached?  

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

   

Date of disclosure:

9 March 2026

Contact name:

William Reeve, Chairman

Telephone number:

+44 (0) 203 709 8733

  Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.   The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.   The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  FEESSUFFUEMSESD